Citadel Advisors’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-11,224
| Closed | -$7.89K | – | 6915 |
|
2022
Q4 | $7.89K | Buy |
11,224
+6,912
| +160% | +$4.86K | ﹤0.01% | 5717 |
|
2022
Q3 | $12K | Buy |
+4,312
| New | +$12K | ﹤0.01% | 5625 |
|
2022
Q2 | – | Sell |
-7,037
| Closed | -$50K | – | 7293 |
|
2022
Q1 | $50K | Buy |
+7,037
| New | +$50K | ﹤0.01% | 5904 |
|
2021
Q3 | – | Sell |
-5,207
| Closed | -$97K | – | 7361 |
|
2021
Q2 | $97K | Buy |
+5,207
| New | +$97K | ﹤0.01% | 5982 |
|
2019
Q1 | – | Sell |
-179
| Closed | -$6K | – | 5186 |
|
2018
Q4 | $6K | Sell |
179
-42
| -19% | -$1.41K | ﹤0.01% | 4434 |
|
2018
Q3 | $34K | Buy |
+221
| New | +$34K | ﹤0.01% | 4057 |
|
2017
Q3 | – | Hold |
0
| – | – | – | 4251 |
|
2017
Q2 | – | Hold |
0
| – | – | – | 4319 |
|
2017
Q1 | – | Sell |
-122
| Closed | -$25K | – | 4305 |
|
2016
Q4 | $25K | Buy |
+122
| New | +$25K | ﹤0.01% | 3417 |
|
2016
Q3 | – | Sell |
-100
| Closed | -$30K | – | 4221 |
|
2016
Q2 | $30K | Buy |
+100
| New | +$30K | ﹤0.01% | 3133 |
|